Europe and Middle East & Africa Gastrointestinal Testing Panels Market Outlook 2031

  • The Europe and Middle East & Africa gastrointestinal testing panels market was valued at US$ 51 Mn in 2020
  • It is estimated to expand at a CAGR of 4.7% from 2021 to 2031
  • The Europe and Middle East & Africa gastrointestinal testing panels market is expected to reach the value of US$ 83.8 Mn by the end of 2031

Analysts’ Viewpoint on Gastrointestinal Testing Panels Market in Europe and Middle East & Africa

Companies in the gastrointestinal testing panels market should accelerate their product development and unlock revenue opportunities to obtain competitive benefits. Market stakeholders are extending their services to gain competitive edge in the healthcare sector. Increasing incidences of gastrointestinal disorders in Europe and Middle East & Africa, along with rapidly increasing elderly population is driving the demand for gastrointestinal testing panels. Moreover, the increasing number of market contributors in EMEA in the gastrointestinal testing panels market are marking their presence and generate lucrative revenue opportunities. Stringent regulations and little knowledge and awareness about the advanced molecular diagnostic methods are factors hampering the growth of the EMEA gastrointestinal testing panels market. In addition, increasing research & development activities in advanced gastrointestinal infection detection methods is fueling the demand for such testing panels, which, in turn, is propelling the growth of the market.

Increasing Availability of Gastrointestinal Testing Panels During COVID-19 Outbreak

With significant impact on the global economy and businesses, the coronavirus pandemic has put intense pressure on the healthcare system of Europe and Middle East & Africa. The gastrointestinal testing panels market in Europe and Middle East & Africa is affected due to insufficient supply of healthcare equipment, shortage of hospital beds, medical staff, etc. However, gastrointestinal testing panels market is booming after the significant efforts taken by healthcare practitioner and market stakeholders to manage the disrupted supply chain. The increasing demand for gastrointestinal testing panels due to rising incidences of gastrointestinal complications in Europe and Middle East & Africa, along with increasing geriatric population drives market growth. Gastrointestinal complications are caused by bacteria, viruses, and parasites, affecting both stomach and small intestine. The gastrointestinal testing panels gives fast and accurate results for analysis of gastrointestinal infection. The Europe and Middle East & Africa gastrointestinal testing panels market is expected to witness steady growth after the coronavirus breakdown, owing to increasing awareness about health.

gastrointestinal testing panels market infographic

Request a sample to get extensive insights into the Gastrointestinal Testing Panels Market

Rising Prevalence of Gastrointestinal Disorders in Europe and Middle East & Africa

The rising prevalence of gastrointestinal disorders in Europe and Middle East & Africa is a major driving factor for the Europe and Middle East & Africa gastrointestinal testing panels market. Unhealthy food habits, hectic lifestyle, disrupted sleep cycle, and excessive stress are some of the key factors responsible for rising incidences of gastrointestinal disorders in Europe and Middle East & Africa. Lack of proper healthcare facilities and unhygienic behavior in some of the emerging countries are the leading causes for increasing cases of diarrheal diseases. Along with diarrhea, abdominal pain and vomiting are the symptoms observed in patients.

The surging growth in patient pool is expected to increase the demand for better gastrointestinal testing panels in Europe and Middle East & Africa. According to the severity of these symptoms, doctors treat the patients using correct diagnosis and proper treatment with the help of gastrointestinal testing panels.

Gastrointestinal testing panel is specifically designed to detect, analyze, and study the gastrointestinal infection using advanced molecular techniques. Viruses, bacteria, and pathogens can be detected using these techniques. Increasing mortality rates due to diarrhea in adults as well as in children is driving the demand for gastrointestinal testing panels in EMEA. Manufacturers in the gastrointestinal testing panels market are targeting on high quality product development due to rising demand and increasing revenue streams. Innovative strategies adopted by healthcare manufacturers to increase the production of gastrointestinal testing devices fuels the market growth.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Increase in Geriatric Population Drives Gastrointestinal Testing Panels Market

The rising geriatric population in Europe and Middle East & Africa is one of the major contributing factors for the growth of the gastrointestinal testing panels market. In Europe and Middle East & Africa, there is a rapid growth in gastrointestinal complications in elderly (people aged over 65 years). These people are highly prone to develop inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, irritable bowel syndrome, etc. Inflammatory bowel diseases in geriatric population are very common. This is due to less regenerative capacity of intestinal stem cells and less production of gastric juice in elderly people. Increasing incidences of gastrointestinal disorders in women in Europe and Middle East & Africa is also a major driving factor of EMEA gastrointestinal testing panels market.

gastrointestinal testing panels market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Gastrointestinal Testing Panels Market

Lucrative Growth Opportunities Due to Advancement in Healthcare Industry

Advancement in healthcare and pharmaceutical industries, increasing healthcare expenditure, and rising geriatric population in EMEA are factors expected to drive the demand for gastrointestinal testing panels during the forecast period. Favorable reimbursement policies in the healthcare industry support market growth. Rising prevalence of gastrointestinal complications and digestive disorders demands for gastrointestinal testing panels on a regular basis. Manufacturers operating in the gastrointestinal testing panels market are increasing the production of these devices to fulfill the demand from the healthcare industry. In order to increase the overall well-being of people, market players are introducing innovative products to cater the increasing demand from hospitals, diagnostic laboratories, etc.

Europe and Middle East & Africa Gastrointestinal Testing Panels Market: Overview

  • According to Transparency Market Research’s latest research report on the gastrointestinal testing panels market in Europe and Middle East & Africa for the historical year 2020 and the forecast period of 2021 to 2031, increase in incidence of gastrointestinal infections such as gastroenteritis, ulcer, and cancer and rise in demand for technologically advanced molecular techniques for detecting infection are projected to drive the market in Europe and Middle East & Africa
  • Growth of the gastrointestinal testing panels market in Europe and Middle East & Africa can be attributed to rise in prevalence and incidence of gastrointestinal diseases such as inflammatory bowel diseases (Crohn's disease and ulcerative colitis), irritable bowel syndrome, and gastroesophageal reflux; increase in the geriatric population; and surge in research & development activities for development of new tests for identifying chronic gastrointestinal disease

Increase in Geriatric Population in MEA: Key Driver of Europe and Middle East & Africa Gastrointestinal Testing Panels Market

  • According to the U.S. Census Bureau, the geriatric population, people aged 65 years and above, has increased significantly in the past few years and is projected to account for over 16.7% of the global population by 2050
  • Prevalence of gastrointestinal disorders is common among the elderly, and around 65% of the geriatric population struggles with different kinds of gastrointestinal complications

Rise in Cases of Gastrointestinal Disorder: Major Driver of Europe and Middle East & Africa Gastrointestinal Testing Panels Market

  • Gastrointestinal disorder affects four in every 10 adults across the globe each year. Moreover, around 200,000 digestive disease-related deaths are reported globally every year. Digestive diseases cause around 50 million visits to physicians and about 10 million hospitalizations every year.

Europe and Middle East & Africa Gastrointestinal Testing Panels Market: Competition Landscape

  • Detailed profiles of providers of gastrointestinal testing panels have been provided in the gastrointestinal testing panels market to evaluate their financials, key product offerings, recent developments, and strategies
  • Key manufacturers of gastrointestinal testing panels focus on designing advanced and cost-effective solutions to attract higher number of customers

Europe and Middle East & Africa Gastrointestinal Testing Panels Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 51 Mn

Market Forecast Value in 2031

US$ 83.8 Mn

Growth Rate (CAGR)

4.7%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Pathogen Type
    • Viruses
    • Bacteria
    • Parasite
  • Type
    • Syndromic Full
    • Multiplex Panel
    • Low Plex Panel
  • End-user
    • Hospitals
    • Diagnostic Laboratories
    • Point-of-Care
    • Others

Regions Covered

  • Europe
  • Middle East & Africa

Countries Covered

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Benelux
  • Poland
  • Norway
  • Sweden
  • Denmark
  • Finland
  • Austria
  • Switzerland
  • Rest of Europe
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Europe and Middle East & Africa Gastrointestinal Testing Panels Market – Scope of Report

The latest study collated and published by Transparency Market Research (TMR) analyzes the historical and present-day scenario of the gastrointestinal testing panels market in EMEA to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the gastrointestinal testing panels market in EMEA in order to identify opportunities for stakeholders. The report also provides insightful information about how the gastrointestinal testing panels market in EMEA would expand during the forecast period of 2021 to 2031.

The report offers intricate dynamics about different aspects of the gastrointestinal testing panels market in EMEA, which aids companies operating in the market in making strategic decisions. TMR’s study also elaborates on the significant changes that are anticipated to configure growth of the gastrointestinal testing panels market in EMEA during the forecast period. It also includes key indicator assessment that highlights growth prospects for the gastrointestinal testing panels market in EMEA and estimates statistics related to the market in terms of value (US$ Mn).

This study covers detailed segmentation of the gastrointestinal testing panels market in EMEA, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the gastrointestinal testing panels market in EMEA, wherein various development, expansion, and winning strategies practiced by these players have been presented in detail.

Key Questions Answered in TMR’s Report on Europe and Middle East & Africa Gastrointestinal Testing Panels Market

The report provides detailed information about the gastrointestinal testing panels market in EMEA based on comprehensive research on various factors that are playing a key role in accelerating the growth of the market. Information mentioned in the report answers path-breaking questions for companies that are currently operating in the gastrointestinal testing panels market in EMEA and are looking for innovative methods to create a unique benchmark in the market in order to help them design successful strategies and make target-driven decisions.

  • Which segment of the gastrointestinal testing panels market in EMEA will emerge as a major revenue generator during the forecast period?
  • How are key market players earning revenue in the gastrointestinal testing panels market in EMEA?
  • What will be the Y-o-Y growth trend of the gastrointestinal testing panels market in EMEA between 2021 and 2031?
  • What are the winning imperatives of leading players operating in the gastrointestinal testing panels market in EMEA?

Research Methodology – Europe and Middle East & Africa Gastrointestinal Testing Panels Market

The research methodology adopted by analysts for compiling the report on the gastrointestinal testing panels market in EMEA is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts of the gastrointestinal testing panels market in EMEA.

During the primary research phase, analysts have interviewed market stakeholders, investors, brand managers, vice presidents, and sales & marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the gastrointestinal testing panels market in EMEA.

For secondary research, analysts have scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the gastrointestinal testing panels market in EMEA.

Europe and Middle East & Africa Gastrointestinal Testing Panels Market – Segmentation

TMR’s research study assesses the gastrointestinal testing panels market in EMEA based on pathogen type, type, end-user, and region. The report presents extensive market dynamics and progressive trends associated with different segments and how they influence growth prospects of the gastrointestinal testing panels market in EMEA.

Pathogen Type
  • Viruses
  • Bacteria
  • Parasite
Type
  • Syndromic Full
  • Multiplex Panel
  • Low Plex Panel
End-user
  • Hospitals
  • Diagnostic Laboratories
  • Point-of-Care
  • Others
Region
  • Europe
  • Middle East & Africa

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe and Middle East & Africa Gastrointestinal Testing Panels Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Gastrointestinal Disorders: Overview

    5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Pathogen Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Pathogen Type, 2017–2031

        6.3.1. Viruses

        6.3.2. Bacteria

        6.3.3. Parasites

7. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Type, 2017–2031

        7.3.1. Syndromic Full Multiplex Panel

        7.3.2. Low Plex Panel

    7.4. Market Attractiveness Analysis, by Type

8. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Diagnostic Laboratories

        8.3.3. Point-of-Care

        8.3.4. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Europe and Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. Europe

        9.2.2. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Country/Region

10. Europe Gastrointestinal Testing Panels Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Pathogen Type, 2017–2031

        10.2.1. Viruses

        10.2.2. Bacteria

        10.2.3. Parasites

    10.3. Market Value Forecast, by Type, 2017–2031

        10.3.1. Syndromic Full Multiplex Panel

        10.3.2. Low Plex Panel

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories

        10.4.3. Point-of-Care

        10.4.4. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. Germany

            10.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.1.1.1. Viruses

                10.5.1.1.2. Bacteria

                10.5.1.1.3. Parasites

            10.5.1.2. Market Value Forecast, by Type, 2017–2031

                10.5.1.2.1. Syndromic Full Multiplex Panel

                10.5.1.2.2. Low Plex Panel

            10.5.1.3. Market Value Forecast, by End-user, 2017–2031

                10.5.1.3.1. Hospitals

                10.5.1.3.2. Diagnostic Laboratories

                10.5.1.3.3. Point-of-Care

                10.5.1.3.4. Others

        10.5.2. U.K.

            10.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.2.1.1. Viruses

                10.5.2.1.2. Bacteria

                10.5.2.1.3. Parasites

            10.5.2.2. Market Value Forecast, by Type, 2017–2031

                10.5.2.2.1. Syndromic Full Multiplex Panel  

                10.5.2.2.2. Low Plex Panel

            10.5.2.3. Market Value Forecast, by End-user, 2017–2031

                10.5.2.3.1. Hospitals

                10.5.2.3.2. Diagnostic Laboratories

                10.5.2.3.3. Point-of-Care

                10.5.2.3.4. Others

        10.5.3. France

            10.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.3.1.1. Viruses

                10.5.3.1.2. Bacteria

                10.5.3.1.3. Parasites

            10.5.3.2. Market Value Forecast, by Type, 2017–2031

                10.5.3.2.1. Syndromic Full Multiplex Panel  

                10.5.3.2.2. Low Plex Panel

            10.5.3.3. Market Value Forecast, by End-user, 2017–2031

                10.5.3.3.1. Hospitals

                10.5.3.3.2. Diagnostic Laboratories

                10.5.3.3.3. Point-of-Care

                10.5.3.3.4. Others

        10.5.4. Italy

            10.5.4.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.4.1.1. Viruses

                10.5.4.1.2. Bacteria

                10.5.4.1.3. Parasites

            10.5.4.2. Market Value Forecast, by Type, 2017–2031

                10.5.4.2.1. Syndromic Full Multiplex Panel  

                10.5.4.2.2. Low Plex Panel

            10.5.4.3. Market Value Forecast, by End-user, 2017–2031

                10.5.4.3.1. Hospitals

                10.5.4.3.2. Diagnostic Laboratories

                10.5.4.3.3. Point-of-Care

                10.5.4.3.4. Others

        10.5.5. Spain

            10.5.5.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.5.1.1. Viruses

                10.5.5.1.2. Bacteria

                10.5.5.1.3. Parasites

            10.5.5.2. Market Value Forecast, by Type, 2017–2031

                10.5.5.2.1. Syndromic Full Multiplex Panel  

                10.5.5.2.2. Low Plex Panel

            10.5.5.3. Market Value Forecast, by End-user, 2017–2031

                10.5.5.3.1. Hospitals

                10.5.5.3.2. Diagnostic Laboratories

                10.5.5.3.3. Point-of-Care

                10.5.5.3.4. Others

        10.5.6. Benelux

                10.5.6.1.1. Viruses

                10.5.6.1.2. Bacteria

                10.5.6.1.3. Parasites

            10.5.6.2. Market Value Forecast, by Type, 2017–2031

                10.5.6.2.1. Syndromic Full Multiplex Panel  

                10.5.6.2.2. Low Plex Panel

            10.5.6.3. Market Value Forecast, by End-user, 2017–2031

                10.5.6.3.1. Hospitals

                10.5.6.3.2. Diagnostic Laboratories

                10.5.6.3.3. Point-of-Care

                10.5.6.3.4. Others

        10.5.7. Poland

            10.5.7.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.7.1.1. Viruses

                10.5.7.1.2. Bacteria

                10.5.7.1.3. Parasites

            10.5.7.2. Market Value Forecast, by Type, 2017–2031

                10.5.7.2.1. Syndromic Full Multiplex Panel  

                10.5.7.2.2. Low Plex panel

            10.5.7.3. Market Value Forecast, by End-user, 2017–2031

                10.5.7.3.1. Hospitals

                10.5.7.3.2. Diagnostic Laboratories

                10.5.7.3.3. Point-of-Care

                10.5.7.3.4. Others  

        10.5.8. Norway

            10.5.8.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.8.1.1. Viruses

                10.5.8.1.2. Bacteria

                10.5.8.1.3. Parasites

            10.5.8.2. Market Value Forecast, by Type, 2017–2031

                10.5.8.2.1. Syndromic Full Multiplex Panel  

                10.5.8.2.2. Low Plex Panel

            10.5.8.3. Market Value Forecast, by End-user, 2017–2031

                10.5.8.3.1. Hospitals

                10.5.8.3.2. Diagnostic Laboratories

                10.5.8.3.3. Point-of-Care

                10.5.8.3.4. Others  

        10.5.9. Sweden

            10.5.9.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.9.1.1. Viruses

                10.5.9.1.2. Bacteria

                10.5.9.1.3. Parasites

            10.5.9.2. Market Value Forecast, by Type, 2017–2031

                10.5.9.2.1. Syndromic Full Multiplex Panel  

                10.5.9.2.2. Low Plex Panel

            10.5.9.3. Market Value Forecast, by End-user, 2017–2031

                10.5.9.3.1. Hospitals

                10.5.9.3.2. Diagnostic Laboratories

                10.5.9.3.3. Point-of-Care

                10.5.9.3.4. Others  

        10.5.10. Denmark

            10.5.10.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.10.1.1. Viruses

                10.5.10.1.2. Bacteria

                10.5.10.1.3. Parasites

            10.5.10.2. Market Value Forecast, by Type, 2017–2031

                10.5.10.2.1. Syndromic Full Multiplex Panel  

                10.5.10.2.2. Low Plex Panel

            10.5.10.3. Market Value Forecast, by End-user, 2017–2031

                10.5.10.3.1. Hospitals

                10.5.10.3.2. Diagnostic Laboratories

                10.5.10.3.3. Point-of-Care

                10.5.10.3.4. Others  

        10.5.11. Finland

            10.5.11.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.11.1.1. Viruses

                10.5.11.1.2. Bacteria

                10.5.11.1.3. Parasites

            10.5.11.2. Market Value Forecast, by Type, 2017–2031

                10.5.11.2.1. Syndromic Full Multiplex Panel  

                10.5.11.2.2. Low Plex Panel

            10.5.11.3. Market Value Forecast, by End-user, 2017–2031

                10.5.11.3.1. Hospitals

                10.5.11.3.2. Diagnostic Laboratories

                10.5.11.3.3. Point-of-Care

                10.5.11.3.4. Others  

        10.5.12. Austria

            10.5.12.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.12.1.1. Viruses

                10.5.12.1.2. Bacteria

                10.5.12.1.3. Parasites

            10.5.12.2. Market Value Forecast, by Type, 2017–2031

                10.5.12.2.1. Syndromic Full Multiplex Panel  

                10.5.12.2.2. Low Plex Panel

            10.5.12.3. Market Value Forecast, by End-user, 2017–2031

                10.5.12.3.1. Hospitals

                10.5.12.3.2. Diagnostic Laboratories

                10.5.12.3.3. Point-of-Care

                10.5.12.3.4. Others  

        10.5.13. Switzerland

            10.5.13.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.13.1.1. Viruses

                10.5.13.1.2. Bacteria

                10.5.13.1.3. Parasites

            10.5.13.2. Market Value Forecast, by Type, 2017–2031

                10.5.13.2.1. Syndromic Full Multiplex Panel  

                10.5.13.2.2. Low Plex Panel

            10.5.13.3. Market Value Forecast, by End-user, 2017–2031

                10.5.13.3.1. Hospitals

                10.5.13.3.2. Diagnostic Laboratories

                10.5.13.3.3. Point-of-Care

                10.5.13.3.4. Others  

        10.5.14. Rest of Europe

            10.5.14.1. Market Value Forecast, by Pathogen Type, 2017–2031

                10.5.14.1.1. Viruses

                10.5.14.1.2. Bacteria

                10.5.14.1.3. Parasites

            10.5.14.2. Market Value Forecast, by Type, 2017–2031

                10.5.14.2.1. Syndromic Full Multiplex Panel  

                10.5.14.2.2. Low Plex Panel

            10.5.14.3. Market Value Forecast, by End-user, 2017–2031

                10.5.14.3.1. Hospitals

                10.5.14.3.2. Diagnostic Laboratories

                10.5.14.3.3. Point-of-Care

                10.5.14.3.4. Others  

    10.6. Market Attractiveness Analysis

        10.6.1. By Pathogen Type

        10.6.2. By Type

        10.6.3. By End-user

        10.6.4. By Country

11. Middle East & Africa Gastrointestinal Testing Panels Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Pathogen Type, 2017–2031

        11.2.1. Viruses

        11.2.2. Bacteria

        11.2.3. Parasites

    11.3. Market Value Forecast, by Type, 2017–2031

        11.3.1. Syndromic Full Multiplex Panel

        11.3.2. Low Plex Panel

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories

        11.4.3. Point-of-Care

        11.4.4. Others

    11.5. Market Value Forecast, by Country, 2017–2031

        11.5.1. GCC Countries

            11.5.1.1. Market Value Forecast, by Pathogen Type, 2017–2031

                11.5.1.1.1. Viruses

                11.5.1.1.2. Bacteria

                11.5.1.1.3. Parasites

            11.5.1.2. Market Value Forecast, by Type, 2017–2031

                11.5.1.2.1. Syndromic Full Multiplex Panel  

                11.5.1.2.2. Low Plex Panel

            11.5.1.3. Market Value Forecast, by End-user, 2017–2031

                11.5.1.3.1. Hospitals

                11.5.1.3.2. Diagnostic Laboratories

                11.5.1.3.3. Point-of-Care

                11.5.1.3.4. Others

        11.5.2. South Africa

            11.5.2.1. Market Value Forecast, by Pathogen Type, 2017–2031

                11.5.2.1.1. Viruses

                11.5.2.1.2. Bacteria

                11.5.2.1.3. Parasites

            11.5.2.2. Market Value Forecast, by Type, 2017–2031

                11.5.2.2.1. Syndromic Full Multiplex Panel  

                11.5.2.2.2. Low Plex Panel

            11.5.2.3. Market Value Forecast, by End-user, 2017–2031

                11.5.2.3.1. Hospitals

                11.5.2.3.2. Diagnostic Laboratories

                11.5.2.3.3. Point-of-Care

                11.5.2.3.4. Others

        11.5.3. Rest of Middle East & Africa

            11.5.3.1. Market Value Forecast, by Pathogen Type, 2017–2031

                11.5.3.1.1. Viruses

                11.5.3.1.2. Bacteria

                11.5.3.1.3. Parasites

            11.5.3.2. Market Value Forecast, by Type, 2017–2031

                11.5.3.2.1. Syndromic Full Multiplex Panel  

                11.5.3.2.2. Low Plex Panel

            11.5.3.3. Market Value Forecast, by End-user, 2017–2031

                11.5.3.3.1. Hospitals

                11.5.3.3.2. Diagnostic Laboratories

                11.5.3.3.3. Point-of-Care

                11.5.3.3.4. Others

    11.6. Market Attractiveness Analysis

        11.6.1. By Pathogen Type

        11.6.2. By Type

        11.6.3. By End-user

        11.6.4. By Country

12. Competition Landscape

    12.1. Company Profiles

        12.1.1. Becton, Dickinson and Company (BD)

            12.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.1.2. Product Portfolio

            12.1.1.3. SWOT Analysis

            12.1.1.4. Strategic Overview

        12.1.2. bioMérieux SA

            12.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.2.2. Product Portfolio

            12.1.2.3. SWOT Analysis

            12.1.2.4. Strategic Overview

        12.1.3. DiaSorin S.p.A (Luminex)

            12.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.3.2. Product Portfolio

            12.1.3.3. SWOT Analysis

            12.1.3.4. Strategic Overview

        12.1.4. Quidel Corporation

            12.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.4.2. Product Portfolio

            12.1.4.3. SWOT Analysis

            12.1.4.4. Strategic Overview

        12.1.5. QIAGEN

            12.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.5.2. Product Portfolio

            12.1.5.3. SWOT Analysis

            12.1.5.4. Strategic Overview

        12.1.6. Seegene, Inc.

            12.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.6.2. Product Portfolio

            12.1.6.3. SWOT Analysis

            12.1.6.4. Strategic Overview

        12.1.7. Savyon Diagnostics

            12.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.7.2. Product Portfolio

            12.1.7.3. SWOT Analysis

            12.1.7.4. Strategic Overview

        12.1.8. CerTest Biotech S.L.

            12.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.8.2. Product Portfolio

            12.1.8.3. SWOT Analysis

            12.1.8.4. Strategic Overview

        12.1.9. Anatolia Geneworks

            12.1.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            12.1.9.2. Product Portfolio

            12.1.9.3. SWOT Analysis

            12.1.9.4. Strategic Overview

List of Tables

Table 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 05: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 06: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 07: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 09: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 10: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 11: Germany Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 12: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 13: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 14: U.K. Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 16: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 17: France Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 18: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 19: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 20: Italy Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 22: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 23: Spain Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 24: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 25: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 26: Benelux Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 27: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 28: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 29: Poland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 30: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 31: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 32: Norway Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 33: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 34: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 35: Sweden Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 36: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 37: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 38: Denmark Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 39: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 40: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 41: Finland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 42: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 43: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 44: Austria Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 45: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 46: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 47: Switzerland Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 48: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 49: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 50: Rest of Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 51: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 52: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 53: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 54: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 55: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 56: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 57: GCC Countries Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 58: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017‒2031

Table 59: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 60: South Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 61: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Pathogen Type, 2017–2031

Table 62: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 63: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Type, 2020

Figure 03: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Region, 2020

Figure 04: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by Pathogen Type, 2020

Figure 05: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share, by End-user, 2020

Figure 06: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 07: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 08: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Viruses, 2017–2031

Figure 09: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Bacteria, 2017–2031

Figure 10: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Parasites, 2017–2031

Figure 11: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 12: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 13: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Syndromic Full Multiplex Panel, 2017–2031

Figure 14: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Revenue (US$ Mn), by Low Plex Panel, 2017–2031

Figure 15: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 16: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 17: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 18: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Diagnostic Laboratories, 2017–2031

Figure 19: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Point-of-Care, 2017–2031

Figure 20: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value (US$ Mn), by Others, 2017–2031

Figure 21: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Region, 2020 and 2031

Figure 22: Europe and Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Region, 2021–2031

Figure 23: Europe Gastrointestinal Testing Panels Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 24: Europe Gastrointestinal Testing Panels Market Value Share, by Country/Sub-region, 2020–2031

Figure 25: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 26: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 27: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 28: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 29: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 30: Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 31: Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 32: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 33: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 34: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 35: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 36: Germany Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 37: Germany Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 38: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 39: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 40: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 41: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 42: U.K. Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 43: U.K. Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 44: France Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 45: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 46: France Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 47: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 48: France Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 49: France Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 50: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 51: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 52: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 53: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 54: Italy Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 55: Italy Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 56: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 57: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 58: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 59: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 60: Spain Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 61: Spain Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 62: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 63: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 64: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 65: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 66: Benelux Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 67: Benelux Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 68: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 69: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 70: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 71: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 72: Poland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 73: Poland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 74: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 75: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 76: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 77: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 78: Norway Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 79: Norway Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 80: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 81: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 82: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 83: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 84: Sweden Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 85: Sweden Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 86: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 87: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 88: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 89: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 90: Denmark Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 91: Denmark Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 92: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 93: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 94: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 95: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 96: Finland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 97: Finland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 98: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 99: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 100: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 101: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 102: Austria Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 103: Austria Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 104: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 105: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 106: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 107: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 108: Switzerland Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 109: Switzerland Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 110: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 111: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 112: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 113: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 114: Rest of Europe Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 115: Rest of Europe Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 116: Middle East & Africa Gastrointestinal Panel Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 117: Middle East & Africa Gastrointestinal Panel Testing Market Value Share, by Country/Sub-region, 2020–2031

Figure 118: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 119: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 120: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 121: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by Type, 2020 and 2031

Figure 122: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by Type, 2021–2031

Figure 123: Middle East & Africa Gastrointestinal Panel Testing Market Value Share Analysis, by End-user, 2020 and 2031

Figure 124: Middle East & Africa Gastrointestinal Panel Testing Market Attractiveness Analysis, by End-user, 2021–2031

Figure 125: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 126: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 127: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 128: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 129: GCC Countries Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 130: GCC Countries Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 131: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type , 2020 and 2031

Figure 132: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 134: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 135: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 136: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 137: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Figure 138: South Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Pathogen Type, 2020 and 2031

Figure 139: South Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Pathogen Type, 2021–2031

Figure 140: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by Type, 2020 and 2031

Figure 141: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by Type, 2021–2031

Figure 142: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Value Share Analysis, by End-user, 2020 and 2031

Figure 143: Rest of Middle East & Africa Gastrointestinal Testing Panels Market Attractiveness Analysis, by End-user, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Gastrointestinal Testing Panels Market